Nobiastx
1 known investors
Find your way into Nobiastx
Sign up to see every warm intro you have to Nobiastx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nobiastx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
Founders & leadership
Investors · 1
Medical Excellence Capitallisted by Medical Excellence CapitalNew York
How we know: Medical Excellence Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 2
Northwest BiotherapeuticsNW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.
Nosis BioNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
Companies working in the same space as Nobiastx.
Frequently asked questions
- What does Nobiastx do?
- Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
- Who founded Nobiastx?
- Nobiastx was founded by Hakon Hakonarson, Brian Halak.
- Who are Nobiastx's investors?
- Nobiastx's investors include Medical Excellence Capital.






